- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AON Issues Comments Against CMS’ 2023 Outpatient Prospective Payment System
American Oncology Network (AON) commented against CMS' proposed CY 2023 Outpatient Prospective Payment System stating it will have grave effects on the sustainability of community oncology practices.
Fort Myers, Fla., August 18, 2022 – American Oncology Network, LLC (AON) expressed their concern regarding CMS' proposed CY 2023 Outpatient Prospective Payment System (OPPS) stating that it will undoubtedly cripple community health care practices.
While practices affiliated with health care systems and hospitals reap the benefits of the OPPS proposals, independent community practices were noted to have to reduce their payment rates to maintain neutrality and receive a decrease in Medicare payments. Moreover, increases in the 340B drug pricing to the average sale price plus 6% and the rise in Medicare reimbursement rates of 2.7% will further limit the ability of community practices to continue providing quality care, services, and medications to their patients.
“Community-based clinics provide high-quality care, services, and resources that are affordable and accessible,” said AON chief medical officer and Genesis Cancer and Blood Institute medical oncologist Stephen “Fred” Divers, MD. “These practices are critical players in closing the cancer care gap and driving health care equity. If they do not receive the support needed to continue providing care in their communities, our health care system has done a disservice to them and failed.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
